申请人:——
公开号:US20030109549A1
公开(公告)日:2003-06-12
A compound of the formula:
1
or a pharmaceutically acceptable salt thereof, wherein R is unsubstituted, mono-, di- or tri-substituted (C
3
-C
11
)cycloalkyl or (C
3
-C
11
)cycloalkenyl or the like, A is unsubstituted (C
1
-C
7
)alkyl or (C
2
-C
5
)alkenyl, or unsubstituted, mono-, di- or tri-substituted aryl, or aromatic-heterocyclic or the like, Y is hydrogen, halo, amino or mercapto, or unsubstituted, mono-, di- or tri-substituted (C
1
-C
10
)alkyl-M—, (C
3
-C
7
)cycloalkyl-M—, (C
2
-C
6
)alkenyl-M—, (C
1
-C
4
)alkyl-NH—((C
1
-C
4
)alkyl)-M—, di(C
1
-C
4
)alkyl-N—((C
1
-C
4
)alkyl)-M—, aryl-M—, aromatic or non-aromatic heterocyclic-M—, aryl-(C
1
-C
5
)alkyl-M— or aromatic non-aromatic heterocyclic-(C
1
-C
5
)alkyl-M—, wherein M is a covalent bond O, S, NH or the like, or the like; Z
1
, Z
2
, Z
3
and Z
4
are hydrogen or the like, has ORL1-receptor agonist activity, and are useful as analgesics or the like in mammalian subjects.
公式为1的化合物或其药学上可接受的盐,其中R为未取代,单取代,双取代或三取代(C3-C11)环烷基或(C3-C11)环烯基或类似物,A为未取代的(C1-C7)烷基或(C2-C5)烯基,或未取代,单取代,双取代或三取代的芳基,或芳香杂环或类似物,Y为氢,卤素,氨基或巯基,或未取代,单取代,双取代或三取代的(C1-C10)烷基-M-,(C3-C7)环烷基-M-,(C2-C6)烯基-M-,(C1-C4)烷基-NH-((C1-C4)烷基)-M-,双(C1-C4)烷基-N-((C1-C4)烷基)-M-,芳基-M-,芳香或非芳香杂环-M-,芳基-(C1-C5)烷基-M-或芳香非芳香杂环-(C1-C5)烷基-M-,其中M是共价键O,S,NH或类似物,或类似物;Z1,Z2,Z3和Z4为氢或类似物,具有ORL1受体激动剂活性,并且在哺乳动物主体中用作镇痛剂或类似物。